AGIO — Agios Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Agios Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,020	783	777	894	854
Net Total Accounts Receivable
Net Total Receivables	4.38	2.21	2.81	4.11	10.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,064	833	834	966	942
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	104	88.1	69.8	54.6	41.2
Long Term Investments
Other Long Term Assets
Total Assets	1,438	1,239	937	1,663	1,297
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	59.8	62.6	68	81.2	82.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	146	138	126	122	104
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,292	1,101	811	1,541	1,193
Total Liabilities & Shareholders' Equity	1,438	1,239	937	1,663	1,297
Total Common Shares Outstanding
Total Preferred Shares Outstanding